Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Bidfudge
    Junior Member
    • Jun 2016
    • 6

    #16
    Feedback on these experiments

    Originally posted by travelk View Post
    I think the original purpose of the Ambion spike-ins was purely as a control to ensure that the lysis buffer was getting to all the wells in the C1 chip and that the RT was working efficiently for each cell (which isn't always the case so the spike-ins have been invaluable to us in that way). I don't think they were intended to be used as a normalization tool, but since they are there, it's tempting to use them. They are simply an artificial, theoretically controlled housekeeping gene in a way.

    Yes, the ERCC spike-ins aren't perfect, but I think they do give a lot of information about the variability of the method in general and specifically in each data set. It's much better to have them and not need them than the other way around (which is what happened with us). I think a lot of new data and bioinformatics methods are going to be coming out in the next year or two and having the right tools available in your data now will allow you to access those methods in the future.

    Hi Travelk,

    Did you published the paper related to the data generated with the C1? I'm facing the same thing, I will have full length RNAseq data from the C1 soon and we used the Spike from Ambion as recommended in the fluidigm's protocol.

    Does the spike from Ambion allow you to normalize these datas?

    Thanks,

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    24 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    20 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    36 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Working...